Injectable drug delivery systems for osteoarthritis and rheumatoid arthritis

MC Bruno, MC Cristiano, C Celia, N d'Avanzo… - ACS …, 2022 - ACS Publications
Joint diseases are one of the most common causes of morbidity and disability worldwide.
The main diseases that affect joint cartilage are osteoarthritis and rheumatoid arthritis, which …

Breakthrough of extracellular vesicles in pathogenesis, diagnosis and treatment of osteoarthritis

Z Liu, Y Zhuang, L Fang, C Yuan, X Wang… - Bioactive …, 2022 - pmc.ncbi.nlm.nih.gov
Osteoarthritis (OA) is a highly prevalent whole-joint disease that causes disability and pain
and affects a patient's quality of life. However, currently, there is a lack of effective early …

Zeta potential of extracellular vesicles: toward understanding the attributes that determine colloidal stability

G Midekessa, K Godakumara, J Ord, J Viil… - ACS …, 2020 - ACS Publications
Extracellular vesicles (EVs), including exosomes and microvesicles (< 200 nm), play a vital
role in intercellular communication and carry a net negative surface charge under …

[HTML][HTML] Commonly used methods for extracellular vesicles' enrichment: Implications in downstream analyses and use

M Clos-Sansalvador, M Monguió-Tortajada… - European Journal of …, 2022 - Elsevier
Extracellular vesicles (EVs) are becoming promising tools for clinical application, either as
sources of disease-specific molecular signatures for the unraveling of disease …

Functionally engineered extracellular vesicles improve bone regeneration

CC Huang, M Kang, Y Lu, S Shirazi, JI Diaz, LF Cooper… - Acta biomaterialia, 2020 - Elsevier
Lineage specific differentiation of host mesenchymal stem cells (MSCs) is a necessary step
for bone repair/regeneration. Clinically, growth factors such as bone morphogenetic protein …

Scaffolds with controlled release of pro-mineralization exosomes to promote craniofacial bone healing without cell transplantation

WB Swanson, Z Zhang, K **u, T Gong, M Eberle… - Acta Biomaterialia, 2020 - Elsevier
Biomimetic bone regeneration methods which demonstrate both clinical and manufacturing
feasibility, as alternatives to autogenic or allogenic bone grafting, remain a challenge to the …

Tumor-targeted exosomes for delivery of anticancer drugs

R Raguraman, D Bhavsar, D Kim, X Ren, V Sikavitsas… - Cancer letters, 2023 - Elsevier
Exosomes are small phospholipid bilayer vesicles that are naturally produced by all living
cells, both prokaryotes and eukaryotes. The exosomes due to their unique size, reduced …

Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine

A González-González… - World journal of …, 2020 - pmc.ncbi.nlm.nih.gov
Mesenchymal stem cells (MSCs) are the most frequently used stem cells in clinical trials due
to their easy isolation from various adult tissues, their ability of homing to injury sites and …

[HTML][HTML] Mesenchymal stem cell exosomes in bone regenerative strategies—a systematic review of preclinical studies

SHS Tan, JRY Wong, SJY Sim, CKE Tjio, KL Wong… - Materials Today Bio, 2020 - Elsevier
The ability of bone for regeneration has long been recognized. However, once beyond a
critical size, spontaneous regeneration of bone is limited. Several studies have focused on …

Extracellular vesicles as delivery systems at nano-/micro-scale

P Fu, J Zhang, H Li, M Mak, W Xu, Z Tao - Advanced drug delivery reviews, 2021 - Elsevier
Extracellular vesicles (EVs) have shown significant promises as nano-/micro-size carriers in
drug delivery and bioimaging. With more characteristics of EVs explored through …